z-logo
Premium
FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs
Author(s) -
Nambiar Sumathi,
Walinsky Sarah,
Schumann Katherine
Publication year - 2021
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.2175
Subject(s) - food and drug administration , drug , medicine , population , antifungal , administration (probate law) , pharmacology , environmental health , political science , law , dermatology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom